These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3875380)

  • 21. Effect of lithium on brain 5-hydroxytryptamine metabolism in mice.
    Shaw JP; Ratcliffe F
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):116-24. PubMed ID: 136232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that taste aversion learning induced by l-5-hydroxytryptophan is mediated peripherally.
    Ervin GN; Carter RB; Webster EL; Moore SI; Cooper BR
    Pharmacol Biochem Behav; 1984 May; 20(5):799-802. PubMed ID: 6610880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):199-202. PubMed ID: 6334429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin release after 5-hydroxytryptophan treatment requires an intact neurointermediate pituitary lobe.
    Johnston CA; Fagin KD; Alper RH; Negro-Vilar A
    Endocrinology; 1986 Feb; 118(2):805-10. PubMed ID: 2417827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice.
    Hiramatsu M
    Neurochem Res; 1983 Sep; 8(9):1163-75. PubMed ID: 6415506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevating serotonin levels in brain with 5-hydroxytryptophan produces hypothermia in rats.
    Lin MT; Chow CF; Chern YF; Wu KM
    Pflugers Arch; 1978 Nov; 377(3):245-9. PubMed ID: 310541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin and 5-hydroxytryptophan on blood pressure and renal blood flow in anesthetized rats.
    Ding XR; Stier CT; Itskovitz HD
    Am J Med Sci; 1989 May; 297(5):290-3. PubMed ID: 2785758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
    Ortmann R; Waldmeier PC; Radeke E; Felner A; Delini-Stula A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):185-92. PubMed ID: 6966764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
    Friedman R; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperleptinemia elicited by the 5-HT precursor, 5-hydroxytryptophan in mice: involvement of insulin.
    Yamada J; Sugimoto Y; Ujikawa M; Goko H; Yagura T
    Life Sci; 2003 Sep; 73(18):2335-44. PubMed ID: 12941435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chlorimipramine and protriptyline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice.
    Modigh K
    J Neural Transm; 1973; 34(2):101-9. PubMed ID: 4541821
    [No Abstract]   [Full Text] [Related]  

  • 33. p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):87-90. PubMed ID: 2986413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain].
    Kitatani T; Hayashi S; Sakaguchi T
    Nihon Yakurigaku Zasshi; 1985 Nov; 86(5):353-8. PubMed ID: 2417922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
    Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
    J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
    Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
    Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
    Pagliusi SR; Löscher W
    Psychopharmacology (Berl); 1985; 86(1-2):118-24. PubMed ID: 2410943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
    Wang X; Baumann MH; Dersch CM; Rothman RB
    Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.